DePuy Synthes Sees Better Execution and Margins in First Quarter

DePuy Synthes reported 1Q24 orthopedic sales of $2,340 million, +4.3% compared to the first quarter of 2023.

The company benefitted from a one-time change in revenue recognition timing on certain products in the U.S. but also had one less selling day in the quarter. Accounting for those items, DePuy Synthes' orthopedic sales grew in the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us